glp-1 lawsuit news today 2025 Ozempic Lawsuits Continue With Second US Mass Litigation Involving Drugs and Vision Loss Alarming rise in weight loss

Glucagon-like peptide-1 receptor agonists, commonly referred to as GLP-1s, are becoming increasingly widespread, with the most notable examples including Ozempic, Wegovy, and Saxenda

The Federation of State Medical Boards (FSMB) maintains a consolidated physician directory at fsmb.org covering all U.S

GLP-1 medications are prescription drugs that should only be used under the guidance of a qualified healthcare professional

In the SURMOUNT-1 clinical trial, participants lost approximately 15-20% of their body weight over 72 weeks, with results varying by dose

Now I have complications from being overweight, but I dont want to have gastric bypass surgery